Press Releases | May 7, 2025
WASHINGTON, D.C. — Patients For Affordable Drugs’ founder and president, David Mitchell, has once again been included in Washingtonian’s Washington DC’s 500 Most Influential People of 2025. This marks the third consecutive year David has been recognized for his tireless work to lower prescription drug prices for patients across the country.
“David’s relentless commitment to reforming the drug price system without taking a penny from industry has made him one of the most trusted and influential voices in Washington on this issue,” said Merith Basey, Executive Director of Patients For Affordable Drugs.
As a cancer patient himself, David’s advocacy is personal, and his influence has helped elevate other patient voices in the media and at the highest levels of government. What began in 2017 with one patient’s story sparked the mobilization of patients across all 50 states with all types of medical conditions, free from pharma funding or influence, and today has turned into a nationwide movement including more than 38,000 patients sharing their stories and championing reforms to lower drug prices. In past years, the Washingtonian called David “an integral player in forcing the prescription-drug provision into the Inflation Reduction Act.” His continued inclusion on this list underscores P4AD’s role in shaping the drug pricing debate as the country faces new challenges and opportunities to address this crisis.
###
Patients For Affordable Drugs is the only national patient advocacy organization focused exclusively on policies that lower prescription drug prices. We empower and mobilize patients by amplifying their experiences with high drug prices to hold those in power to account and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. P4AD does not accept funding from organizations that profit from the development and distribution of drugs. To learn more, visit PatientsForAffordableDrugs.org.